Bioequivalence and Bioavailability Forum

Main page Policy/Terms of Use Abbreviations Latest Posts

 Log-in |  Register |  Search

Back to the forum  Query: 2017-12-12 22:43 CET (UTC+1h)

Fed VS Fast state in BE studies [Design Issues]

posted by M.tareq - 2017-02-26 09:34  - Posting: # 17110
Views: 1,970

Dear all ,.
question about fed state design and fast one in a modified release drug

due to expected high variability in fed state study we will use partial replicate design,
however there's no expected high variability in fast state (PPI drug)
my question is the design for the fed state should be the same for fast one ? i.e partial replicate ? and the basis for that if yes, mean we are comparing the test in fed state vs ref in fed state and vice versa

N.B according to EMA guidelines

Thanks in advance

best regards

Complete thread:

Back to the forum Activity
 Mix view
Bioequivalence and Bioavailability Forum | Admin contact
17,555 Posts in 3,758 Threads, 1,089 registered users;
25 users online (1 registered, 24 guests).

Enlightenment is man’s emergence from his self-imposed nonage
for which he himself was responsible.
Nonage is the inability to use one’s own intellect
without the direction of another.    Immanuel Kant

BEBAC Ing. Helmut Schütz